Penserra Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,544
| Closed | -$113K | – | 1356 |
|
|
2023
Q3 | $113K | Buy |
8,544
+1,350
| +19% | +$17.9K | ﹤0.01% | 868 |
|
|
2023
Q2 | $134K | Buy |
7,194
+1,144
| +19% | +$21.3K | ﹤0.01% | 890 |
|
|
2023
Q1 | $87K | Buy |
6,050
+440
| +8% | +$6.33K | ﹤0.01% | 789 |
|
|
2022
Q4 | $108K | Sell |
5,610
-8,109
| -59% | -$156K | ﹤0.01% | 798 |
|
|
2022
Q3 | $471K | Buy |
13,719
+10,819
| +373% | +$371K | 0.01% | 444 |
|
|
2022
Q2 | $44K | Buy |
2,900
+860
| +42% | +$13K | ﹤0.01% | 929 |
|
|
2022
Q1 | $46K | Buy |
+2,040
| New | +$46K | ﹤0.01% | 1029 |
|